Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R McCurdy

Showing results (211-220 of 220) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 220 results.
Journal of Medicinal Chemistry|September 1, 2021
Activity of <i>Mitragyna speciosa</i> ("Kratom") Alkaloids at Serotonin ReceptorsFrancisco León, Samuel Obeng, Marco Mottinelli, et al.
Molecules (Basel, Switzerland)|July 12, 2025
Dual Opioid-Neuropeptide FF Small Molecule Ligands Demonstrate Analgesia with Reduced Tolerance LiabilitiesMarco Mottinelli, V Blair Journigan, Samuel Obeng, et al.
Traffic Injury Prevention|March 18, 2024
Effects of kratom on driving: Results from a cross-sectional survey, ecological momentary assessment, and pilot simulated driving StudyC Austin Zamarripa, Tory R Spindle, Leigh V Panlilio, et al.
European Journal of Medicinal Chemistry|April 13, 2023
Studies on diketopiperazine and dipeptide analogs as opioid receptor ligandsSiavash Shahbazi Nia, Mohammad Anwar Hossain, Guangchen Ji, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 5, 2023
Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in RatsShyam H Kamble, Samuel Obeng, Francisco León, et al.
Scientific Reports|August 26, 2021
Effects of the sigma-1 receptor agonist blarcamesine in a murine model of fragile X syndrome: neurobehavioral phenotypes and receptor occupancySamantha T Reyes, Robert M J Deacon, Scarlett G Guo, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 24, 2022
Interactive Effects of <i>µ</i>-Opioid and Adrenergic-<i>α</i> <sub>2</sub> Receptor Agonists in Rats: Pharmacological Investigation of the Primary Kratom Alkaloid Mitragynine and Its Metabolite 7-HydroxymitragynineSamuel Obeng, Francisco Leon, Avi Patel, et al.
Nature Medicine|December 4, 2019
A selective BCL-X<sub>L</sub> PROTAC degrader achieves safe and potent antitumor activitySajid Khan, Xuan Zhang, Dongwen Lv, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 2021
Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for <i>μ</i>-Opioid Receptor and Opioid-Like Behavioral Effects in RatsSamuel Obeng, Jenny L Wilkerson, Francisco León, et al.
European Journal of Pharmacology|July 28, 2024
The Mitragyna speciosa (kratom) alkaloid mitragynine: Analysis of adrenergic α<sub>2</sub> receptor activity in vitro and in vivoSamuel Obeng, Morgan L Crowley, Marco Mottinelli, et al.
Pageof 22

Showing results (211-220 of 220) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 220 results.
Journal of Medicinal Chemistry|September 1, 2021
Activity of <i>Mitragyna speciosa</i> ("Kratom") Alkaloids at Serotonin ReceptorsFrancisco León, Samuel Obeng, Marco Mottinelli, et al.
Molecules (Basel, Switzerland)|July 12, 2025
Dual Opioid-Neuropeptide FF Small Molecule Ligands Demonstrate Analgesia with Reduced Tolerance LiabilitiesMarco Mottinelli, V Blair Journigan, Samuel Obeng, et al.
Traffic Injury Prevention|March 18, 2024
Effects of kratom on driving: Results from a cross-sectional survey, ecological momentary assessment, and pilot simulated driving StudyC Austin Zamarripa, Tory R Spindle, Leigh V Panlilio, et al.
European Journal of Medicinal Chemistry|April 13, 2023
Studies on diketopiperazine and dipeptide analogs as opioid receptor ligandsSiavash Shahbazi Nia, Mohammad Anwar Hossain, Guangchen Ji, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 5, 2023
Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in RatsShyam H Kamble, Samuel Obeng, Francisco León, et al.
Scientific Reports|August 26, 2021
Effects of the sigma-1 receptor agonist blarcamesine in a murine model of fragile X syndrome: neurobehavioral phenotypes and receptor occupancySamantha T Reyes, Robert M J Deacon, Scarlett G Guo, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 24, 2022
Interactive Effects of <i>µ</i>-Opioid and Adrenergic-<i>α</i> <sub>2</sub> Receptor Agonists in Rats: Pharmacological Investigation of the Primary Kratom Alkaloid Mitragynine and Its Metabolite 7-HydroxymitragynineSamuel Obeng, Francisco Leon, Avi Patel, et al.
Nature Medicine|December 4, 2019
A selective BCL-X<sub>L</sub> PROTAC degrader achieves safe and potent antitumor activitySajid Khan, Xuan Zhang, Dongwen Lv, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 2021
Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for <i>μ</i>-Opioid Receptor and Opioid-Like Behavioral Effects in RatsSamuel Obeng, Jenny L Wilkerson, Francisco León, et al.
European Journal of Pharmacology|July 28, 2024
The Mitragyna speciosa (kratom) alkaloid mitragynine: Analysis of adrenergic α<sub>2</sub> receptor activity in vitro and in vivoSamuel Obeng, Morgan L Crowley, Marco Mottinelli, et al.
Pageof 22